US FDA approves Pfizer’s Inlyta for kidney cancer – Reuters

January 28, 2012

WANE

US FDA approves Pfizer's Inlyta for kidney cancer
Reuters
By Anna Yukhananov | WASHINGTON (Reuters) – Pfizer's Inlyta drug for patients with advanced kidney cancer won approval from US regulators, boosting the company's efforts to offset plunging Lipitor sales. The Food and Drug Administration on Friday said …
Pfizer Wins US Approval for Advanced Kidney-Cancer DrugBusinessWeek
FDA approves targeted Pfizer drug for patients with recurring kidney cancerWashington Post
US clears Pfizer drug for advanced kidney cancer The Associated Press
MedPage Today
all 200 news articles »

Login to view full review:

Pfizer Wins US Approval for Advanced Kidney-Cancer Drug – BusinessWeek
FDA clears Pfizer drug for advanced kidney cancer – Wall Street Journal
Pfizer Kidney Drug Gains FDA Approval – Wall Street Journal
Bayer Birth Control Pill Benefits Outweigh Risks, Panel Says – BusinessWeek
FDA disapproves cancer delightment – Bend Bulletin

Tagged with: Advanced Cancer, Associated Press, Businessweek, Cancer Drug, Fda, Food And Drug, Food And Drug Administration, Kidney Cancer, Lipitor, News Articles, Pfizer, Pfizer Drug, Reuters, Washington Post, Wins

Categorised as: hot babe